arbor-logo-tree-color.png
Arbor Strengthens Focus on Therapeutics with Key Additions to Leadership Team
20 juil. 2021 08h00 HE | Arbor Biotechnologies Inc
- Pam Stetkiewicz, Ph.D., Appointed Chief Operating Officer - Kathryn McCabe, Ph.D., Named SVP, Head of Business Development CAMBRIDGE, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- Arbor...
22157.jpg
Global Gene Therapy Market 2021-2027 - COVID-19 Causes Gene Therapy Market to Buckle & Collapse
13 juil. 2021 03h28 HE | Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Gene Therapy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global market for Gene Therapy...
22157.jpg
Global $34.31 Billion Cell and Gene Therapy Markets, 2015-2020, 2025F, 2030F
12 juil. 2021 04h38 HE | Research and Markets
Dublin, July 12, 2021 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy market Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to...
22157.jpg
Global Cell Therapy Market Report 2021 Featuring Fibrocell Science., JCR Pharma, PHARMICELL, Osiris, MEDIPOST, Vericel, Anterogen, Kolon TissueGene, Stemedica Cell Technologies, and AlloCure
30 juin 2021 04h33 HE | Research and Markets
Dublin, June 30, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global cell...
Intellia and Regeneron Announce Landmark Clinical Data Showing Deep Reduction in Disease-Causing Protein After Single Infusion of NTLA-2001, an Investigational CRISPR Therapy for Transthyretin (ATTR) Amyloidosis
26 juin 2021 11h15 HE | Intellia Therapeutics, Inc.
First-ever clinical data supporting safety and efficacy of in vivo CRISPR genome editing in humans Interim readout in ongoing Phase 1 trial finds single 0.3 mg/kg dose of NTLA-2001 led to 87% mean...
arbor-logo-tree-color.png
Arbor Biotechnologies to Present at the Raymond James Human Health Innovation Conference
21 juin 2021 08h00 HE | Arbor Biotechnologies Inc
CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next generation of genetic medicines, announced today...
Graphical Research.jpg
Animal Model Market Size & Share | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
21 juin 2021 05h00 HE | Graphical Research
Pune, India, June 21, 2021 (GLOBE NEWSWIRE) -- The global animal model market size is poised to expand at substantial CAGR during the forecast period owing to increase in the number of scientific...
22157.jpg
CRISPR and Cas Genes Markets, 2028 by Product & Service (Vector-based Cas, DNA-free Cas), Application (Biomedical, Agriculture)
16 juin 2021 06h08 HE | Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "CRISPR and Cas Genes Market Size, Share & Trends Analysis Report by Product & Service (Vector-based Cas, DNA-free Cas), by Application...
Intellia.jpg
Intellia Therapeutics to Present Interim Clinical Data from Ongoing Phase 1 Study of NTLA-2001 for the Treatment of Transthyretin (ATTR) Amyloidosis at the 2021 Peripheral Nerve Society Annual Meeting
04 juin 2021 07h30 HE | Intellia Therapeutics, Inc.
Data to offer insight into safety and pharmacodynamics of NTLA-2001, the first-ever systemically administered in vivo CRISPR therapy candidateLate-breaking abstract selected for oral presentation on...
arbor-logo-tree-color.png
Arbor Biotechnologies to Present at the Evercore ISI GenomeRx Emerging Therapeutics Conference and the Jefferies Virtual Healthcare Conference
02 juin 2021 08h00 HE | Arbor Biotechnologies Inc
CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next generation of genetic medicines, announced today...